Eisai
4523.T
#2142
Rank
A$13.05 B
Marketcap
A$46.25
Share price
3.73%
Change (1 day)
5.26%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2026 (TTM): A$0.57 Billion

According to Eisai's latest financial reports the company's current earnings are A$5.44 Billion. In 2025 the company made an earning of A$0.61 Billion a decrease over its 2024 earnings that were of A$0.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.57 B-7.16%
2025 A$0.61 B-20.48%
2024 A$0.77 B2.42%
2023 A$0.76 B-2404.04%
2022 -A$33.02 Million-103.6%
2021 A$0.91 B-39.81%
2020 A$1.52 B7.44%
2019 A$1.41 B17.22%
2018 A$1.21 B86.16%
2017 A$0.65 B-23.52%
2016 A$0.85 B26.97%
2015 A$0.66 B22.3%
2014 A$0.54 B-46.07%
2013 A$1.01 B-21.85%
2012 A$1.29 B-20.59%
2011 A$1.63 B-8.91%
2010 A$1.79 B19.21%
2009 A$1.50 B